Registered Trials

• EUCTR2020-004066-19, NCT04674189

  Phase 3

  Germany

  Total Enrollment: 2,520

  Official Trial Registration:

  • EUCTR2020-004066-19(Opens in new tab/window)
  • NCT04674189(Opens in new tab/window)

• NCT04838847

  Phase 3

  Total Enrollment: 180

  Official Trial Registration:

  • NCT04838847(Opens in new tab/window)

• NCT04848467

  Phase 3

  Argentina, Colombia, Peru

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT04848467(Opens in new tab/window)

• NCT04860258

  Phase 3

  Belgium

  Total Enrollment: 1,200

  Official Trial Registration:

  • NCT04860258(Opens in new tab/window)

• NCT04652102, EUCTR2020-003998-22

  Phase 2/3

  Argentina, Belgium, Colombia, Dominican Republic, France, Germany, Mexico, Netherlands, Panama, Peru, Spain

  Total Enrollment: 39,693

  Official Trial Registration:

  • NCT04652102(Opens in new tab/window)
  • EUCTR2020-003998-22(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• NCT04515147, PER-054-20

  Phase 2

  Panama, Peru

  Total Enrollment: 660

  Official Trial Registration:

  • NCT04515147(Opens in new tab/window)
  • PER-054-20(Opens in new tab/window)

• NCT04449276

  Phase 1

  Belgium, Germany

  Total Enrollment: 280

  Official Trial Registration:

  • NCT04449276(Opens in new tab/window)